Feasibility, safety and initial efficacy of cathepsin-activatable fluorescent probes for molecular detection of colorectal and esophageal neoplasiaView Poster
Feasibility, safety and efficacy of cathepsin-activatable fluorescent probes for molecular detection of pancreatic adenocarcinomaView Poster
Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancerView Poster
Use of cathepsin-activatable fluorescent agent to rapidly distinguish tumors versus normal tissue in multiple tumor typesView Poster
Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity margins using the LUM Imaging System: Results of a feasibility study
Feasibility of the LUM Imaging System for real-time, intraoperative detection of residual breast cancer in lumpectomy cavity marginsView Poster
Events & Presentations
San Antonio Breast Cancer Symposium
December 4-8, 2018 in San Antonio, TX
This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.
San Antonio Breast Cancer Symposium
October 21-25, 2018 in Boston, MA
The ACS Clinical Congress features outstanding education and training opportunities at the premier annual surgical meeting for surgeons, surgery residents, medical students, and members of surgical teams. The hallmarks of the Clinical Congress are a broad range of outstanding hands-on and didactic learning opportunities and timely discourse on the most relevant surgical practices and research, along with unparalleled access to peers.
American College of Surgeons
American Society of Breast Surgeons 19th Annual Meeting
May 2-6, 2018 in Orlando, FL
The American Society of Breast Surgeons, the primary leadership organization for general surgeons who treat patients with breast disease, is committed to continually improving the practice of breast surgery by serving as an advocate for surgeons who seek excellence in the care of breast patients. Our mission is accomplished by providing a forum for the exchange of ideas and by promoting education, research, and the development of advanced surgical techniques.
American Society of Breast Surgeons
April 29-May 1, 2018 in Orlando, FL
The SOS focuses on the importance of the multi-disciplinary approach in the pre-op assessment and the practical elements of how to perform Oncoplastic procedures. Didactic lectures feature experts in breast surgery (oncology & aesthetic/reconstructive surgery), radiology, radiation oncology, pathology, and the psychosocial aspects of breast care. A coding specialist will also be part of the faculty and will be available for the duration of the course to answer questions.
School of Oncoplastic Surgery
Cleveland Breast Cancer Summit: Collaborating for a Cure
April 19 & 20, 2018 in Cleveland, Ohio
The Cleveland Clinic Comprehensive Breast Cancer Program presents the 2018 Cleveland Breast Cancer Summit: Collaborating For A Cure, a live educational multi-disciplinary summit focusing on up-to-date reviews of advances in management strategies for patients with breast cancer and comorbidities. The activity will offer, the most up to date and cutting edge information about breast cancer from screening to treatment. The goal of this summit is to increase the competencies and performance of healthcare professionals involved in treating this patient population, which ultimately will improve the quality of life and overall patient survival.
TARGIT Collaborative Group Annual Conference
April 13 & 14, 2018 in Las Vegas, Nevada
The TARGIT Collaborative Group (TCG) is a cooperative effort between radiation oncologists, cancer surgeons, physicists and other experts in intraoperative radiotherapy that share a common commitment to improving cancer patient care through education, patient advocacy, mentorship, and collaborative research.
March 21-24, 2018 Chicago, Illinois
The ways in which surgical patients with solid tumor cancers are treated change and evolve every day. Critical progress is being made, exciting innovations unveiled and new discoveries continually emerge. The SSO Annual Cancer Symposium is where you go to learn about the array of research developments, clinical trials, new technology, and future trends in cancer care. And much of what you’ll learn at SSO 2018 can immediately be integrated into your treatment of oncology surgery patients.
SOLUTIONS with/in/sight: Cells in the City; by The Koch Institute at MIT
November 29, 2017
They may not have won seven Emmys and eight Golden Globes; yet projects from the Koch Institute Frontier Research Program have hit the big time! Join MIT’s Koch Institute for Integrative Cancer Research for an evening of presentations and conversation about two daring cancer research projects turned start-up, breaking new ground as they enter the marketplace and move into the clinic. SQZ Biotechnologies is disrupting both cell membranes and biopharma with its cell-squeezing technology for cell therapies, including promising new-to-immunotherapy approaches. Lumicell illuminates cancer at the cellular level, for real-time action during surgery and forward-thinking action in industry. Hear from lead scientists and their corporate partners about their journeys from bench to biotech, and find out how grassroots funding from the Koch Institute’s signature Frontier Research Program helped propel these high-risk ideas into high-reward technology. 6:00 to 8:30 PM
Institute for Biomedical Entrepreneurship (IBE) Certificate Session
September 13 - 17, 2017
The IBE brings the specialized know-how and the funding required for translational development success. In addition, the IBE provides biomedical researchers and innovators with educational programs and hands-on training that will help them become more aware of how to make their discoveries end up in the marketplace. Kelly Londy, CEO of Lumicell, will present as a guest faculty member in a session titled “Scientific Validation, Scientific Replication and the Commercial Pathway” on Friday, September 15 from 1:45 to 3:00 p.m.
The 2nd International Prostate Cancer Symposium and Inaugural World Congress of Urologic Oncology
September 6-9, 2017
The Mount Sinai Urology Department will host a live interactive state-of-the-art educational symposium. The program will include 3D demonstrations of the latest robotic surgery techniques for prostate, kidney and bladder cancer. Directed by the world’s leading robotic experts and taught by an internationally renowned faculty. Format includes point – counterpoint debates, didactic lectures and abstract presentations. Lumicell will have a booth at this event.
The Convergence of Medical Devices & Drugs: The Future of Combination Products
May 12, 2017
Combination products are essential tools for patient care and continue to be an area of active and exciting development. From diffusion based polymer systems to complex delivery devices utilizing diagnostic sensors and sophisticated control systems for precise and timely delivery of life-saving agents, a diverse set of scientific and engineering disciplines are being brought to bear within this space. However, combination products involve components normally developed under different types of regulations, design criteria and controls. This symposium will explore many of the diverse aspects impacting combination products. W. David Lee, President of Lumicell, will be the Keynote Speaker.
December 6-10, 2016
World Medical Innovation Forum
April 25-27, 2016, Breakthrough Devices to Treat Cancer